ProJini
Itai Bloch has extensive work experience in the field of computational chemistry and drug discovery. Itai is the Co-founder and Scientific Advisor at Eggmented Reality since May 2022. Prior to that, they worked as a Scientific Advisor at MigVax starting from March 2020. Itai co-founded ProJini AgChem in December 2019, where they served as the Co-Founder and CSO. At ProJini AgChem, they focused on developing solutions targeting protein-protein interactions using computational-biophysical methods.
Itai Bloch worked as a Computational Chemistry and Drug Discovery Principal Investigator at MIGAL Galilee Research Institute from September 2012. Itai'swork there involved the rational design of new vaccines and protein-based therapeutics.
Itai also has previous work experience at Dynamix Pharmaceuticals, where they held the position of Senior Scientist from May 2010 to August 2012 and R&D Scientist in Computational Drug Discovery from June 2009 to June 2010. Similarly, they worked as an R&D Scientist in Computational Drug Discovery at EPIX Pharmaceuticals from April 2007 to June 2009.
Itai Bloch has a Bachelor of Science (B.Sc) degree in Biophysics, which was obtained between the years 2000 and 2003. Following this, Itai pursued a Master of Science (M.Sc) degree in Chemistry with a specialization in Structural Biology from 2003 to 2006.
This person is not in any teams
ProJini
ProJini Agchem is developing a solution focused on new type of molecular targets: protein-protein interactions. While such interactions are at the core of any organism, it is very challenging to develop inhibitors for such systems via conventional approaches due to their spatial and chemical characteristics. The platform, developed by scientistsMaayan Gal, PhD and Itay Bloch at the Migal Galilee Research Institute Ltd., leverages a combination of computational-biophysical methods to tackle this significant challenge. ProJini Agchem received an exclusive license to use this platform to develop novel pesticides with new modes of action.